Alliance Pharma (LSE:APH) Price-to-Operating-Cash-Flow : 6.47 (As of Apr. 29, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma Price-to-Operating-Cash-Flow?

As of today (2024-04-29), Alliance Pharma's share price is £0.3495. Alliance Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.05. Hence, Alliance Pharma's Price-to-Operating-Cash-Flow Ratio for today is 6.47.

The historical rank and industry rank for Alliance Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

LSE:APH' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.06 Med: 12.94 Max: 19.56
Current: 6.47

During the past 13 years, Alliance Pharma's highest Price-to-Operating-Cash-Flow Ratio was 19.56. The lowest was 6.06. And the median was 12.94.

LSE:APH's Price-to-Operating-Cash-Flow is ranked better than
86.39% of 676 companies
in the Drug Manufacturers industry
Industry Median: 17.435 vs LSE:APH: 6.47

Alliance Pharma's Cash Flow from Operations per share for the six months ended in Jun. 2023 was £0.03. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.05.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Alliance Pharma was -12.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -17.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -0.80% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 5.00% per year.

During the past 13 years, Alliance Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 75.00% per year. The lowest was -78.10% per year. And the median was 9.30% per year.

Alliance Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Alliance Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma Price-to-Operating-Cash-Flow Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

15.58

12.55

11.38

15.32

13.95

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	15.32	-	13.95	-

Competitive Comparison of Alliance Pharma's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alliance Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's Price-to-Operating-Cash-Flow falls into.

Alliance Pharma Price-to-Operating-Cash-Flow Calculation

Alliance Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.3495	/	0.054
	=	6.47

Alliance Pharma's Share Price of today is £0.3495.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Alliance Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was £0.05.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Alliance Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).